| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/04/1993 | CA2115262A1 In-vivo gene transfer using implanted retroviral producer cells |
| 03/04/1993 | CA2114434A1 Screening methods for immunosuppressive agents |
| 03/04/1993 | CA2114016A1 Methods and compositions for modulating g protein action |
| 03/03/1993 | EP0530167A1 New isosteric peptides |
| 03/03/1993 | EP0529995A1 Human KA-2 receptor, a kainate high affinity receptor of the EAA2 (Excitatory Amino Acid) family |
| 03/03/1993 | EP0529858A1 2-Piperazinone compounds, their production and use |
| 03/03/1993 | EP0529622A2 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/03/1993 | EP0529584A2 Viral agent associated with the Mystery Swine Disease |
| 03/03/1993 | EP0529568A1 Novel orally-active elastase inhibitors |
| 03/03/1993 | EP0529499A1 Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
| 03/03/1993 | EP0529487A2 PACAP derivatives having c-AMP producing activity |
| 03/03/1993 | EP0529410A2 Antibiotic GE 2270 factor C2a |
| 03/03/1993 | EP0529300A1 Novel recombinant human-IFN-beta, process for the preparation thereof and pharmaceutical compositions comprising the same |
| 03/03/1993 | EP0529160A1 Gene protein products and methods of cell therapy |
| 03/03/1993 | EP0529086A1 Processes for purifying human bcdf |
| 03/03/1993 | EP0529075A1 Hybrid calcitonin |
| 03/03/1993 | EP0529065A1 Receptor-based screening methods for amylin agonists and antagonists |
| 03/03/1993 | EP0529033A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 03/03/1993 | EP0529031A1 Improved inhibitors of thrombin |
| 03/03/1993 | EP0529030A1 Composition of antibodies directed against the humain or animal interleukin-2 receiver |
| 03/03/1993 | EP0529023A1 Therapeutically useful peptides and peptides fragments |
| 03/03/1993 | EP0528979A1 $i(TRANS)-DOMINANT SUPPRESSOR GENES FOR OLIGOMERIC PROTEINS |
| 03/03/1993 | EP0528951A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
| 03/03/1993 | EP0528949A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample. |
| 03/03/1993 | EP0528931A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0528891A1 Method for increasing blood-brain barrier permeability |
| 03/03/1993 | EP0528881A1 Methods for phenotype creation from multiple gene populations |
| 03/03/1993 | EP0528875A1 Enzymatic disinsertion of vitreous body |
| 03/03/1993 | EP0528861A1 Composition and treatment with biologically active peptides and toxic cations |
| 03/03/1993 | EP0528841A1 A method for the preparation of pyridoxylated hemoglobin |
| 03/03/1993 | EP0528835A1 Cyclic peptides and their use |
| 03/03/1993 | EP0528820A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase. |
| 03/03/1993 | EP0517805A4 Identification and expression of insect steroid receptor dna sequences |
| 03/03/1993 | EP0512076A4 Method of treating cancer using structured lipids |
| 03/03/1993 | EP0419501B1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| 03/03/1993 | EP0363400B1 Method and apparatus for preparing composite skin replacement |
| 03/03/1993 | EP0310639B1 Omega-3 fatty acids in traumatic injury treatment |
| 03/03/1993 | EP0233901B1 A method and composition for regulating serum calcium levels of mammals |
| 03/03/1993 | EP0211013B1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms |
| 03/03/1993 | CN1069522A Intercellular adhesion molecule-3 and its binding ligands |
| 03/03/1993 | CN1069519A Preparing method for ginseng wine of strengthening "yang" |
| 03/02/1993 | US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions |
| 03/02/1993 | US5190970 Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 03/02/1993 | US5190969 2,3-epoxy derivatives as anti retrovital chemotherapeutic agents |
| 03/02/1993 | US5190957 Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones |
| 03/02/1993 | US5190931 Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
| 03/02/1993 | US5190924 Peptide amides and amide dimers useful as muscle relaxants |
| 03/02/1993 | US5190923 Peptide compounds containing a cyclic amide structure |
| 03/02/1993 | US5190922 Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands |
| 03/02/1993 | US5190921 Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments |
| 03/02/1993 | US5190920 Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity |
| 03/02/1993 | US5190919 Antihemostatic factor vii peptides |
| 03/02/1993 | US5190918 Peptide fragments and analogs of thrombospondin and methods of use |
| 03/02/1993 | US5190917 Mast cell and T-cell inhibitor |
| 03/02/1993 | US5190916 Use of ovomacroglobulin as an agent for treating wound and inflammation |
| 03/02/1993 | US5190876 Method of modifying cellular differentiation and function and compositions therefor |
| 03/02/1993 | US5190859 Purification of LFA-3 |
| 03/02/1993 | US5190858 Bonding tissues |
| 03/02/1993 | US5190765 Latent Drug Delivery |
| 03/02/1993 | US5190762 DNA repair enzymes encapsulated in liposomes |
| 03/02/1993 | US5190756 Methods and materials for expression of human plasminogen variant |
| 03/02/1993 | US5190753 3-phenyl-5,6-dihydrobenziciacridine-7-carboxylic acids and related compounds as immunosuppressive agents |
| 03/02/1993 | US5190752 Intravenously administerable polyclonal immunoglobulin preparation containing igm and method of manufacture |
| 03/02/1993 | US5190751 Treatment of certain leukemias with a combination of gamma interferon and alpha interferon |
| 03/02/1993 | US5190750 Antiinflammatory agents, tumor necrosis factor, treatment of multiple sclerosis |
| 03/01/1993 | WO1993005152A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2094242A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2076995A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 02/27/1993 | WO1993004080A1 Pseudopentapeptides with immunomodulating activity |
| 02/27/1993 | CA2094822A1 Pseudopentapeptides with immunomodulating activity |
| 02/24/1993 | EP0528767A1 Antibody derivatives |
| 02/24/1993 | EP0528716A1 Human hemoglobin derivatives, process for preparing them, products derived therefrom and use of these derivatives and products |
| 02/24/1993 | EP0528701A1 Process of preparation of a human thrombin concentrate for therapeutic use |
| 02/24/1993 | EP0528663A2 Monoclonal antibody to a synaptophysin |
| 02/24/1993 | EP0528661A2 HIV protease inhibitors with N-terminal polyether substituents |
| 02/24/1993 | EP0528633A1 Pyrimidinyl acetamides as elastase inhibitors |
| 02/24/1993 | EP0528583A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
| 02/24/1993 | EP0528527A2 Conjugates |
| 02/24/1993 | EP0528500A2 A method for reduction of central nervous system (CNS) edema resulting from head and spinal cord trauma |
| 02/24/1993 | EP0528486A2 Non-substrate inhibitors of farnesyl protein transferase |
| 02/24/1993 | EP0528469A1 Recombinant DNA-molecule for the expression of the FV-fragment of an antibody |
| 02/24/1993 | EP0528458A1 Method for controlling dental tartar using phosphopeptides and compositions for use therein |
| 02/24/1993 | EP0528314A1 Process for the preparation of bearable medicine containing an human protein for injection or infusion |
| 02/24/1993 | EP0528313A1 Process for the preparation of a preserved medicine containing an human protein for injection of infusion |
| 02/24/1993 | EP0528312A2 Cyclic peptides and use thereof |
| 02/24/1993 | EP0528242A2 Trifluoromethyl containing pseudopeptides |
| 02/24/1993 | EP0528034A1 Remedy for asthma |
| 02/24/1993 | EP0528011A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 02/24/1993 | EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/24/1993 | EP0527971A1 Composition and method for immunostimulation in mammals |
| 02/24/1993 | EP0527916A1 Antisense inhibitors of the human immunodeficiency virus |
| 02/24/1993 | EP0527914A1 Novel synthetic grf analogs |
| 02/24/1993 | EP0527889A1 Quinolizinone type compounds |
| 02/24/1993 | EP0527822A1 T-cell suppressor protein |
| 02/24/1993 | EP0527815A1 Hepatitis c virus epitopes |
| 02/24/1993 | EP0527806A1 Epithelins: novel cysteine - rich growth modulating proteins |
| 02/24/1993 | EP0527804A1 Gene therapy for cell proliferative diseases |
| 02/24/1993 | EP0527802A1 Ligand for the neu gene product. |
| 02/24/1993 | EP0527789A1 Hiv envelope polypeptides |